NCT04233749View on ClinicalTrials.gov

The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans

PHASE2RecruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 17, 2020

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Lichen Planus PigmentosusErythema Dyschromicum PerstansAshy Dermatosis of Ramirez
Interventions
DRUG

Tranexamic acid tablets

325mg of tranexamic acid twice daily for six months

Trial Locations (1)

48202

RECRUITING

New Center One, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER